Welcome to Baxter BioSurgery.

Baxter Healthcare Corporation advanced the field of wound management over 30 years ago with the development of TISSUCOL in over 40 countries worldwide, and 10 years of TISSEEL experience in the U.S. as a tissue sealant and hemostat.^1,2

Today, the company continues its quest for advancing BioSurgery by offering a comprehensive line of biological products for hemostasis and sealing, adhesion reduction solution, and preparation/delivery devices based on the latest scientific advances in the field. Our products give you speed, consistency and ease-of-use that are state of the art.

For more product information, please mouse over the icons and select a product.

References:

1. Data on file; Pharmacovigilance data. Baxter Healthcare Corporation, 11/7/07.
2. TISSEEL [Fibrin Sealant] Full Prescribing Information, 12/2007.